Dr. Logan Spector

Probably the public has seen they've moved around the ideal age of mammograms for breast cancer.

Um, and, uh, absolutely the, uh, recognition that, you know, early onset colorectal cancer is epidemic now.

Um, we, we, we say epidemic when, uh, you know, even if it's not an infectious disease, if something's just kind of risen everywhere all at once and, um,

But it's a tough situation because when you screen a population, all right, if the incidence is not that high, you get more false positives than true positives, all right?

Meaning you're going to worry a lot of people, you know, many more people than –

than are going to get saved.

And so it's really like a numbers game.

And, you know, even though it's been rising by 50%, that's the relative rise, you know, and in absolute numbers, early onset colorectal cancer is still pretty rare.

All right.

At least compared to the, you know, over 50s.

And so really science has to do better with the method of screening.

So when a disease is rare, like if your screening test isn't,

just spot on, then you will just worry a lot more people, the so-called false positives.

And that can have real consequences.

You surely know about the prostate cancer screening.

They moved to the PSA test, the prostate specific antigen test.

a lot of uptake because, you know, that's based on a urine test rather than the digital rectal exam.

And, um, but it turns out that there are basically every man over 50 has like a, an incipient prostate, uh, cancer.

Right.

And, um,